Navigantis Inc. announced today the first successful neurovascular clinical cases performed with its VASCO interventional robotic platform for patients suffering from neurovascular disorders.
MIAMI, Dec. 27, 2024 /PRNewswire/ -- Navigantis Inc. announced today the first successful neurovascular clinical cases performed with its VASCO interventional robotic platform for patients suffering ...
It is speculated that compromised circulatory function, as can be seen in inflammatory vascular conditions such as atherosclerosis, may impact the regulation of cerebrovascular blood flow in response ...
The neurovascular devices market accounted for $2,935 million in 2019, and is expected to reach $3,712 million by 2027, registering a CAGR of 5.2% from 2020 to 2027. These devices are used in ...
nottingham.ac.uk Background: Normal adult articular cartilage is thought to be avascular and aneural. Objective: To describe neurovascular structures at the osteochondral junction and in osteophytes ...
December 3, 2024—Route 92 Medical, Inc. recently announced that its line of neurovascular intervention products has received CE Mark approval under the European Union (EU) Medical Device Regulation ...
at 09:00 NAVIGANTIS VASCOtm Robotic Platform Used with First Patients Enrolled in Neurovascular Study Navigantis Inc. announced today the first successful neurovascular clinical cases performed with ...